New Biorepository and GxP Archive Facility Opened by VWR

Mayor Kelly Burk joins the celebration of their new archival and biorepository facility in Leesburg, VA. (PRNewsfoto/VWR)
Advertisement img

The global clinical trials and research outsourcing (CRO) market is expected to reach revenues of USD $64.58 billion by 2021 according to Frost & Sullivan. The clinical trials supply market in the USA alone has been estimated to be worth USD $980 million in 2018 (Grand View Research). Storage and distribution is anticipated to develop the fastest growth at a compound annual growth rate (CAGR) of over 7.0%.

VWR is a wholly owned subsidiary of Avantor. To expand its CRO footprint VWR has recently acquired MESM and Therapak clinical supplies companies. In order to better serve the growing clinical trials industry VWR has boosted its Clinical and Biorepository Services by acquiring EPL Archives, LLC, in 2017, a firm dedicated to the consolidation, preservation, and GxP management of a wide variety of research and manufacturing biomaterials. EPL reduces risk, removes stress and boosts their customer’s efficiency with harmonized processes.

EPL Archives provides clinical biorepository and biobanking services, biological storage, non-clinical good laboratory practice (GLP) archiving, regulated data management, secure waste disposal, specialised logistics and support services. The combined companies of VWR and EPL have opened their first new facility, a 24-acre campus and purpose-built biorepository in Leesburg, VA. It offers over 155,000 square feet of new storage capacity, designed to support the full spectrum of professional biorepository services.

Featured Partners

The new VWR Clinical and Biorepository Services alliance of MESM, Therapak and EPL Archives is intended to be a unique combination of expertise engaged in optimising clinical operations, sample management, whole product lifecycle support, and configurable kit manufacturing. Biorepositories and biobanking are key components of modern clinical trials and long-term follow-up studies, especially when biomarkers are used. Avantor, VWR and the Clinical and Biorepository Services alliance is well placed to supply and serve the global expansion of clinical trial requirements with the aid of the new Leesburg facility.